Abstracts Archive - Page 355 of 1683 - ATC Abstracts

2020 American Transplant Congress
Influence of Microbial Communities on Transplantation
K. Janek¹, J. Fechner¹, K. Krautkramer², S. Sudakaran³, J. Denu⁴, J. Handelsman³, F. Rey⁵, E. Vivas⁵, J. Mezrich¹
¹Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, ²University of Wisconsin School of Medicine and Public Health, Madison, WI, ³Wisconsin Institute for Discovery, Madison, WI, ⁴Biomolecular Chemistry, University of Wisconsin-Madison, Madison, WI, ⁵Bacteriology, University of Wisconsin-Madison, Madison, WI
*Purpose: A diverse microbiome is important in the generation, maintenance, and function of the immune system. Specific bacterial communities may have a relationship with organ…
2020 American Transplant Congress
TGF-b Induced Myeloid-Derived Suppressor Cells Prevent Transplatation Rejection by Promoting Immune Tolerance
P. Cao, Z. Sun, J. Zhang, F. Zhang, W. Wang
Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
*Purpose: Myeloid-derived suppressor cells (MDSCs) are a class of heterogeneous myeloid cells with immunosuppressive function. An effective method to produce MDSCs with better capacity and…
2020 American Transplant Congress
The Role of Antigen Presentation in B Regulatory Cell Function
A. Cuenca¹, N. Feeney², K. Deng², Q. Fu², G. Huai², C. Rickert², K. Lee², J. Markmann²
¹Boston Children's Hospital, Boston, MA, ²Massachusetts General Hospital, Boston, MA
*Purpose: B regulatory cells (B regs) represent a subset of B cells with non-canonical regulatory function. The majority of effort has been focused on the…
2020 American Transplant Congress
Long Term Liver Transplant Survivors
M. Haberal¹, E. Ayvazoglu Soy¹, G. Moray¹, F. Ozcay², A. Torgay³
¹Department of General Surgery, Division of Transplantation, Baskent University, Ankara, Turkey, ²Pediatric Nephrology, Baskent University, Ankara, Turkey, ³Anaesthesia, Baskent University, Ankara, Turkey
*Purpose: Few reports mentioned about long term survey. In this study, we aimed to report the outcomes of our long term LT survivors (LTS).*Methods: Our…
2020 American Transplant Congress
Effects of Donor Heavy Alcohol Use on Post-Heart Transplant Outcomes: Time to Abstain?
J. Patel, M. Kittleson, D. Chang, E. Kransdorf, D. Geft, A. Shen, K. Nishihara, G. Jamero, L. Czer, F. Esmailian, J. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Donors with a history of heavy alcohol use have been suspected to possibly harbor a subclinical alcoholic cardiomyopathy with limited cardiac reserve. This problem…
2020 American Transplant Congress
Liver Transplantation for Primary Liver Sarcoma in Children-The US Experience from the Scientific Registry for Transplant Recipients (1988-2018)
A. Amin, K. Soltys, S. Ranganathan, G. Bond, A. Khanna, A. Ganoza, Q. Sun, G. Mazariegos, R. Sindhi
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Primary liver sarcomas (PLS) are rare tumors and encompass subtypes with diverse histology and varying outcomes. These subtypes include embryonal sarcoma (ES), rhabdomyosarcoma (RMS),…
2020 American Transplant Congress
A Simple Scoring System for Risk Stratification in Liver Transplantation after Donor Liver Biopsy
J. A. Steggerda, M. B. Bloom, K. Mahendraraj, T. Ramos, T. Todo, T. V. Brennan, N. N. Nissen, A. S. Klein, I. K. Kim
Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA
*Purpose: Macrosteatosis (MaS) identified on donor liver biopsy (DLBx) influences organ utilization but alone is not predictive of outcomes following liver transplantation (LT). Here we…
2020 American Transplant Congress
11 Years Experience of Early Steroid Withdrawal Immunosupression Protocol in Kidney Allograft Recipient
O. Adebiyi, A. Sharfuddin, M. Yaqub, D. Mishler, T. Taber, W. Goggins
Indiana University, Indianapolis, IN
*Purpose: Early Steroid Withdrawal (ESW) Immunosuppression protocol has become a viable alternative to steroid based regimen. Our transplant program has adopted ESW protocol since 2003…
2020 American Transplant Congress
MY-ATLAS: A Novel Simulation Algorithm for Liver Transplant Allocation
C. G. Rickert¹, H. Zhao², Z. Leung², M. Akan³, J. F. Markmann¹, S. Tayur³, H. Yeh¹
¹Surgery, Massachusetts General Hospital, Boston, MA, ²City University of Hong Kong, Hong Kong, China, ³Tepper School of Business, Carnegie Mellon University, Pittsburgh, PA
*Purpose: Currently, the primary tool for modeling expected outcomes from changes in allocation policy is the SRTR-run Liver Simulated Allocation Model (LSAM), which is neither…
2020 American Transplant Congress
The Link between Waitlist Mortality and Access to Transplant, an Imaginative Reality
R. Batra¹, D. Mulligan¹, D. Haakinson¹, S. Noreen², D. Stewart², G. Gan³, Y. Deng³, S. Kulkarni¹
¹Surgery, Yale University School of Medicine, New Haven, CT, ²UNOS, Richmond, VA, ³Yale University, New Haven, CT
*Purpose: Liver transplant waitlist mortality due to inadequate access to livers is the Achilles heel in liver transplantation in United States. This remains amongst the…